Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulations, 2015
Filed with BSE · · 3 pages · English
Summary by 6ix AI
Clinitech Laboratory Limited submitted a statement of deviation or variation regarding the utilization of funds raised through a public issue, as required by regulations. The report confirms that there has been no deviation or variation in the use of the funds as of the end of September. All funds raised have been fully utilized for the disclosed purposes, including expansion and corporate expenses.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/statement-of-deviation-or-variation-under-regulation-32-of-sebi-lodr-regulations-2015-1
Clinitech Laboratory Limited on 6ix
Story so far
Earlier from Clinitech Laboratory
- Unaudited Standalone & Consolidated Financial Results For The Half Year Ended September 30, 2026
- Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E On Friday, November 13, 2026 At 12.00 Noon (IST) Through Video Conferencing
- Board Meeting Intimation for We Wish To Inform You That The Meeting Of The Board Of Directors Of The Company Will Be Held On Friday, November 13, 2026 Through Video Conferencing At 12.00 Noon (IST)
- Non-Applicability Of Regulation 23 Of SEBI (LODR) Regulations, 2015 W.R.T Related Party Transactions
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Clinitech Laboratory
All Clinitech Laboratory news releasesFollow Clinitech Laboratory into a list and get an email when it puts out news.
Follow Clinitech Laboratory